Management

show all hide all

John S. Thievon

President and Chief Executive Officer

John Thievon has served as President & Chief Executive Officer and a Director on our board since September 2008. Prior to joining MiddleBrook, he was with Adams Respiratory Therapeutics, Inc. for 9 years. He held various positions there. From May 2005 through February 2008, John was an Executive Vice President with Adams. He oversaw sales operations and the field sales team, corporate accounts, business development and commercial operations, among other things. John was Vice President of Sales and Professional Marketing from May 2000 to May 2005 where he wrote the marketing plan for the launch of Mucinex®. Before that John also worked in the positions of Northeast Regional Business Director and Director of Marketing with Adams.

John worked for IMS Health Inc., from January 1995 to December 1998. At IMS he worked in several positions including Account Manager, Account Director, and Director of Sales Training. He was a Sales Representative with Ortho Pharmaceuticals, Inc. from 1990 to 1994.

Since November 2007, John has been a member of DaySpring Pharma, LLC's Board of Directors. DaySpring is a specialty pharmaceutical company focused on acquiring, developing and commercializing prescription and non-prescription products for specialty markets in women's health and pediatrics. John graduated from Pace University with a Bachelor of Business Administration degree, with a concentration in marketing.

Dave Becker

Executive Vice President and Chief Financial Officer

David Becker has been our Executive Vice President, Chief Financial Officer since September 2008. Prior to joining us, Dave served as an independent consultant to various healthcare companies from March 2007 to June 2008, providing them with chief financial officer and/or chief executive officer services. In addition, Dave sat on the board of directors for several of these healthcare companies. From 2000 to 2007, Dave served as the Chief Financial Officer and Treasurer of Adams Respiratory Therapeutics, Inc. and served in various other capacities with Adams over that period including Chief Financial and Administrative Officer from October 2006 to February 2007, and interim Chief Operating Officer from May 2003 to April 2004. Prior to joining Adams, Mr. Becker was a Senior Manager in the merger and acquisitions practice of Ernst & Young LLP from November 1997 to September 2000. From January 1996 to November 1997, Mr. Becker served as Controller for the Salt Lake City-based start-up company RxAmerica LLC, a pharmacy benefit management and mail-service pharmacy operation. From 1991 to 1995, he served as a financial auditor with Ernst & Young LLP. Mr. Becker began his professional career in 1990 as an audit and tax accountant for the southern California-based accounting firm of Glenn M. Gelman & Associates. Mr. Becker earned a bachelor's degree in accounting in 1990 from the University of Southern Mississippi and is a certified public accountant and certified treasury professional.

Susan P. Clausen, Ph.D.

Senior Vice President, Clinical Research and Medical Affairs

Susan P. Clausen, Ph.D., was appointed senior vice president, clinical research and medical affairs in September 2008. Prior to that, Dr. Clausen was the vice president, clinical research and regulatory affairs since December 2004. She joined the company as Senior Director, Clinical Research in September 2003. From 1994 to 2003, Dr. Clausen was employed at Shire Pharmaceutical Development. While at Shire, she held management positions with increasing responsibilities in the biopharmaceutical and clinical research organizations. As the senior director of clinical research, Dr. Clausen was responsible for clinical development programs in various therapeutic areas including central nervous system, oncology, virology and gastrointestinal disorders. Prior to working at Shire, Dr. Clausen gained additional experience at TSI/ Mason Research Laboratories and at Harvard Medical School as a post-doctoral research fellow. She received a Bachelor of Science (Hons) in chemistry from University College, Dublin, Ireland, a Master of Science in Forensic Science from Strathclyde University, Glasgow, Scotland and a doctorate in forensic toxicology from the University of Illinois at Chicago.

Brad Cole

Senior Vice President, General Counsel and Secretary

Brad Cole has served as our Senior Vice President, General Counsel and Secretary since September 2008. He was the Associate General Counsel and Assistant Secretary at Adams Respiratory Therapeutics, Inc. from August 2004 to July 2008. From August 1999 to July 2004, he was with the law firm of Holland & Knight LLP, in the firms Tampa office and focused on corporate, securities and M&A matters. Brad began his career in the financial services industry and worked at several financial institutions from 1991 to 1994. Brad earned a bachelor's degree from the University of Miami in 1990;his Juris Doctorate, cum laude, from Thomas M. Cooley Law School in 1998; and a Masters of Laws in Securities and Financial Regulations, with honors, from the Georgetown University Law Center, in May 1999.

Timothy L. Miller

Senior Vice President, Commercial Operations

Timothy L. Miller has served as our Senior Vice President, Sales Operations & Administration since September 2008. Prior to joining us, Tim served as the Vice President Sales Operations & Training at Adams Respiratory Therapeutics, Inc. from September 2004 to July 2008. From 1986 to 2004, he held various positions at Aventis Pharmaceuticals and its legacy companies, including Hoechst Marion Roussel, Marion Merrell Dow, and Marion Labs. Tim's positions at Aventis and its legacy companies included Financial Analyst, Manager Commercial Financial Services, Regional Business Manager, Senior Manager Sales Information & Incentives, and Director Sales Operations. Tim graduated from Emporia State University in 1978 earning a Bachelor of Science in Business, with a concentration in accounting. Tim received his Master in Business Administration in 1983, with a concentration in finance, from Rockhurst University, a Jesuit institution in Kansas City.

Donald J. Treacy, Ph.D

Senior Vice President, Pharmaceutical Development and Quality

Donald J. Treacy, Ph.D. has served as our vice president, analytical sciences since January 2004. Dr. Treacy joined us as director, analytical research and development in March 2000. Dr. Treacy has 13 years of industry experience including 12 years in drug development and novel drug delivery systems.

From 1993 to 2000, Dr. Treacy was employed at Shire Laboratories, Inc./Pharmavene. While at Shire Laboratories, he held management positions with increasing responsibilities in analytical method development, validation, clinical trial material release and NDA stability. Prior to that, Dr. Treacy performed analytical method development and photodegradation research at the National Cancer Institute. Dr. Treacy has a bachelor's degree from Roanoke College and received a Ph.D. in analytical chemistry from the University of Maryland.